Millennium Pharmaceuticals, Inc.

(NASDAQ:MLNM)

24.97

0.00 (0.00%)

Jan 07 - Close

Open
24.97
High
24.97
Low
24.97
Vol.
N/A
Mkt Cap
8.17B
52Wk High
25.00
52Wk Low
9.49
Avg. Vol.
7.85M
P/E (Trailing)
227.00
Beta
0.00
Short %
5.30%
Div. Yield
—

Company Profile

Millennium Pharmaceuticals, Inc.

40 Landsdowne Street

Cambridge, MA 02139

United States - Map

Phone: (617) 679-7000

Fax: (617) 374-7788

Website: www.mlnm.com

State of incorporation: Delaware

CEO: Dr. Deborah Dunsire, M.D.

Employees: 966

Sector: Healthcare

Industry Group: Drugs

Industry: Drug Manufacturers - Other

Dev genetically based drug to treat obesity

A biopharmaceutical company focused on discovering, developing and commercializing medicines to improve the lives of patients with cancer, inflammatory bowel diseases and other inflammatory diseases.

Recent news for MLNM

Members owning MLNM also own

GFF (33.33%), HCC (33.33%), HE (33.33%), KCI (33.33%), LNT (33.33%)

Member sentiment (?)    Neutral

- MarketGuru Blog network-

Top members owning MLNM

* Average monthly return vs. S&P 500

Recent opinions on MLNM

No recent Opinions for MLNM